BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND uPA AND Treatment
31 results:

  • 1. The Important Role of GPX1 and NF-κB Signaling Pathway in Human gastric cancer: Implications for Cell Proliferation and Invasion.
    Jang BI; Jung JY; Koh SA; Lee KH
    Cancer Genomics Proteomics; 2024 Apr; 21(3):305-315. PubMed ID: 38670589
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Allyl isothiocyanate inhibits cell migration and invasion in human gastric cancer AGS cells via affecting PI3K/AKT and MAPK signaling pathway in vitro.
    Lin TS; Huang WN; Yang JL; Peng SF; Liu KC; Chen JC; Hsia TC; Huang AC
    Environ Toxicol; 2023 Oct; 38(10):2287-2297. PubMed ID: 37318315
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Vernodalin Suppresses Tumor Proliferation and Increases Apoptosis of gastric cancer Cells Through Attenuation of FAK/PI3K/AKT/mTOR and MAPKs Signaling Pathways.
    Luo Y; Zhang D; Hou L; Lin N
    Curr Pharm Biotechnol; 2023; 24(5):708-717. PubMed ID: 35909270
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Sinulariolide Inhibits gastric cancer Cell Migration and Invasion through Downregulation of the EMT Process and Suppression of FAK/PI3K/AKT/mTOR and MAPKs Signaling Pathways.
    Wu YJ; Lin SH; Din ZH; Su JH; Liu CI
    Mar Drugs; 2019 Nov; 17(12):. PubMed ID: 31783709
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Diallyl disulfide inhibits the metastasis of type Ⅱ esophageal‑gastric junction adenocarcinoma cells via NF-κB and PI3K/AKT signaling pathways in vitro.
    Yin X; Feng C; Han L; Ma Y; Jiao Y; Wang J; Jia L; Jing F; Gao X; Zhang Y; Zhang J
    Oncol Rep; 2018 Feb; 39(2):784-794. PubMed ID: 29207122
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Quercetin Has Antimetastatic Effects on gastric cancer Cells via the Interruption of upa/upaR Function by Modulating NF-κb, PKC-δ, ERK1/2, and AMPKα.
    Li H; Chen C
    Integr Cancer Ther; 2018 Jun; 17(2):511-523. PubMed ID: 28627240
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis.
    Brungs D; Chen J; Aghmesheh M; Vine KL; Becker TM; Carolan MG; Ranson M
    Oncotarget; 2017 Apr; 8(14):23099-23109. PubMed ID: 28416743
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Matrine Suppresses Proliferation and Invasion of SGC7901 Cells through Inactivation of PI3K/Akt/upa Pathway.
    Peng X; Zhou D; Wang X; Hu Z; Yan Y; Huang J
    Ann Clin Lab Sci; 2016 Sep; 46(5):457-62. PubMed ID: 27650610
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Clinical Study of Urokinase-Type Plasminogen Activator and Vascular Endothelial Growth Factor in gastric cancer.
    Yang XW; Gao F; Chen YJ; Teng FM
    Cell Biochem Biophys; 2015 Jul; 72(3):649-52. PubMed ID: 27352182
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Suppressive effects on cell proliferation and motility in gastric cancer SGC-7901 cells by introducing ulinastatin in vitro.
    Wang J; Chen X; Su L; Zhu Z; Wu W; Zhou Y
    Anticancer Drugs; 2016 Aug; 27(7):651-9. PubMed ID: 27187019
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Suppression of IL-8-Src signalling axis by 17β-estradiol inhibits human mesenchymal stem cells-mediated gastric cancer invasion.
    Liu CJ; Kuo FC; Wang CL; Kuo CH; Wang SS; Chen CY; Huang YB; Cheng KH; Yokoyama KK; Chen CL; Lu CY; Wu DC
    J Cell Mol Med; 2016 May; 20(5):962-72. PubMed ID: 26945908
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Identification of potential targets for diallyl disulfide in human gastric cancer MGC-803 cells using proteomics approaches.
    Su B; Su J; He H; Wu Y; Xia H; Zeng X; Dai W; Ai X; Ling H; Jiang H; Su Q
    Oncol Rep; 2015 May; 33(5):2484-94. PubMed ID: 25812569
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. IL-1β-stimulated urokinase plasminogen activator expression through NF-κB in gastric cancer after HGF treatment.
    Lee KH; Choi EY; Koh SA; Kim MK; Jang BI; Kim SW; Kim JR
    Oncol Rep; 2014 May; 31(5):2123-30. PubMed ID: 24626561
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. u-PA inhibitor amiloride suppresses peritoneal metastasis in gastric cancer.
    Ding Y; Zhang H; Zhou Z; Zhong M; Chen Q; Wang X; Zhu Z
    World J Surg Oncol; 2012 Dec; 10():270. PubMed ID: 23234499
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Down-regulation of survivin suppresses uro-plasminogen activator through transcription factor JunB.
    Lee KH; Choi EY; Koh SA; Kim MK; Kim KO; Lee SH; Jang BI; Kim SW; Kim SW; Song SK; Choi JH; Kim JR
    Exp Mol Med; 2011 Sep; 43(9):501-9. PubMed ID: 21734448
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Gastrin stimulates expression of plasminogen activator inhibitor-1 in gastric epithelial cells.
    Nørsett KG; Steele I; Duval C; Sammut SJ; Murugesan SV; Kenny S; Rainbow L; Dimaline R; Dockray GJ; Pritchard DM; Varro A
    Am J Physiol Gastrointest Liver Physiol; 2011 Sep; 301(3):G446-53. PubMed ID: 21193525
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Effects of S-adenosylmethionine on gastric cancer cell lines SGC-7901 and BGC-823].
    Zhao Y; Li JS; Guo MZ; Feng BS; Zhang JP; Chen XY
    Zhonghua Yi Xue Za Zhi; 2010 Jun; 90(22):1559-64. PubMed ID: 20973239
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Inhibitory effect of S-adenosylmethionine on the growth of human gastric cancer cells in vivo and in vitro.
    Zhao Y; Li JS; Guo MZ; Feng BS; Zhang JP
    Chin J Cancer; 2010 Aug; 29(8):752-60. PubMed ID: 20663323
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Phenethyl isothiocyanate inhibits migration and invasion of human gastric cancer AGS cells through suppressing MAPK and NF-kappaB signal pathways.
    Yang MD; Lai KC; Lai TY; Hsu SC; Kuo CL; Yu CS; Lin ML; Yang JS; Kuo HM; Wu SH; Chung JG
    Anticancer Res; 2010 Jun; 30(6):2135-43. PubMed ID: 20651362
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Reactive oxygen species regulate urokinase plasminogen activator expression and cell invasion via mitogen-activated protein kinase pathways after treatment with hepatocyte growth factor in stomach cancer cells.
    Lee KH; Kim SW; Kim JR
    J Exp Clin Cancer Res; 2009 Jun; 28(1):73. PubMed ID: 19497102
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.